THE results of our testing many typical sulphanilamide derivatives for antibacterial activity having convinced us that the compounds more active and more polyvalent in therapeutic action than sulphanilamide should be searched for amongst its (N1)-sulphonamide substituted derivatives,' the synthesis of such a class of compounds was undertaken. As suitable substituents for this purpose, we chose the significant radicals or ring systems present in the reputed antiseptics, chemotherapeuticals of undoubted value in the treatment of the protozoal infections and also the compounds with vital biochemical functions such as the vitamins, coenzymes, nucleic acids, etc. After a trial of the various radicals and ring systems (the results obtained are being published), success was met with in the thiazole derivatives and the very impressive results obtained by us with one of them, 2-Nl-sulphanilamidothiazole (sulphathiazole) in some experimental infections' and clinical trials in plague 3 have already been published. This paper presents the list of compounds further synthesised in accordance with our scheme (a preliminary report of which has already been published4). Since the immediate programme at hand is a preliminary survey of the various ring systems for anti-bacterial activity and we had to reap the maximum benefit of the very limited stock of chemicals available, only typical representatives of each group were prepared and tested to trace the direction in which further elaboration would be expected to be profitable. As is inevitable and is also becoming a rather common experience in this field wherein a large number of investigators are rushing for new and more potent compounds, there is much overlapping of work. Thus, some of the compounds prepared and tested here have been reported by other researchers also. 5,6. 7 Though in our synthesis of sulphanilamidothiazole with substituents at the positions 4 or 5 or both in the thiazole ring, we were anticipated by a patent of Messrs. May and Baker, 8 we are still continuing our studies because the therapeutic properties of most of them have not yet been reported. 
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